At least in pre-clinical research, there’s also a mechanism by which regulatory agencies can sometimes force industry to pay for replication studies. It’s a lit

At least in pre-clinical research, there’s also a mechanism by which regulatory agencies can sometimes force industry to pay for replication studies. It’s a little complicated, because sometimes there aren’t many groups who can reliably do the study, and clinical trials are so expensive and time-consuming to run, it would be difficult to do at that scale. Rodent studies are generally under $1M and monkey studies are generally under $5M (up a lot recently). Clinical trials are in the hundreds of millions of dollars and take years to run.